A Telehealth Advance Care Planning Intervention for Older Patients With Myeloid Malignancies: A Pilot Randomized Controlled Trial

Status: Recruiting

Location: See location...

Intervention Type: Behavioral, Other

Study Type: Interventional

Study Phase: Not Applicable

SUMMARY

The objective of this project is to conduct a pilot randomized trial to assess the preliminary efficacy of a telehealth-delivered Serious Illness Care Program on healthcare communication, patient anxiety and distress, as well as completion of advance directives (specifically MOLST and healthcare proxy forms) for older patients with acute myeloid leukemia, myelodysplastic syndrome, and similar myeloid malignancies.

Eligibility

Participation Requirements

Sex: All

Minimum Age: 60

Healthy Volunteers: f

View:

• Age ≥60 years

• A diagnosis of AML, MDS, and similar myeloid malignancies (including but not limited to MDS/MPN overlap syndrome, myelofibrosis)

• Being managed in the outpatient settings

• Able to provide informed consent

• English-speaking

• Age ≥18 years

• Selected by patient when asked if there is a family member, partner, friend, or caregiver with whom you discuss or who can be helpful in health-related matters

• Able to provide informed consent

• English-speaking

⁃ \- Oncologists and/or APPs who will be conducting the telehealth-delivered ACP visit

Locations

United States

New York

University of Rochester

RECRUITING

Rochester

Contact Information

Primary

Kah Poh Loh, MD

Kahpoh_Loh@URMC.Rochester.edu

585-276-4353

Backup

Becky Gravenstede

becky_gravenstede@urmc.rochester.edu

585-727-4728

Time Frame

Start Date: 2024-05-20

Estimated Completion Date: 2025-12-31

Participants

Target number of participants: 207

Treatments

Experimental: Telehealth Serious Illness Care Program

The adapted telehealth Serious Illness Care Program is a multilevel intervention engaging the patient, caregiver, clinician, and system. It consists of tools, training, and system change. Tools include: 1) The Serious Illness Conversation Guide for clinicians; and 2) Education materials for patients on the importance of Serious Illness Conversations (Patient Preparation Pamphlet) and of the involvement of caregivers (Family Communication Guide).

Other: Control

Education materials developed by the NCI on Communication in Cancer Care (PDQ®) - Patient Version

Related Therapeutic Areas

Acute Myeloid Leukemia (AML)

Myelofibrosis

Leukemia

Myelodysplastic Syndrome (MDS)

Similar Clinical Trials

View All

A Telehealth Advance Care Planning Intervention for Older Patients With Myeloid Malignancies: A Pilot Randomized Controlled Trial

Similar Clinical Trials

A Phase 1, Open-Label, Safety and Tolerability Study of INCB057643 in Participants With Myelofibrosis and Other Advanced Myeloid Neoplasms

A Phase 1, Open-Label, Safety and Tolerability Study of INCB057643 in Participants With Myelofibrosis and Other Advanced Myeloid Neoplasms

A Pilot Study to Determine the Safety and Efficacy of Incorporating Hyperbaric Oxygen Therapy Into RIC Fludarabine and Melphalan and Allogeneic Hematopoietic Stem/Progenitor Transplantation

A Pilot Study to Determine the Safety and Efficacy of Incorporating Hyperbaric Oxygen Therapy Into RIC Fludarabine and Melphalan and Allogeneic Hematopoietic Stem/Progenitor Transplantation

A Phase 1, Open-label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of GLB-001 in Patients With Myeloid Malignancies

A Phase 1, Open-label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of GLB-001 in Patients With Myeloid Malignancies